Blue Note Therapeutics raises $26M to help treat cancer-related distress via cognitive behavioral stress management (CBSM)

By SharpBrains | March 9, 2021

Blue Note Ther­a­peu­tics Rais­es $26.25 Mil­lion in Series A Financ­ing (press release): Blue Note Ther­a­peu­tics, Inc., today announced the clos­ing of a Series A financ­ing round of $26.25 mil­lion. Pro­ceeds will allow the com­pa­ny to scale the orga­ni­za­tion and fund near-term clin­i­cal tri­als of its lead pre­scrip­tion dig­i­tal ther­a­peu­tic (PDT), which will poten­tial­ly improve the…

Read More

Pear Therapeutics raises $50M to develop and market a portfolio of digital therapeutics for mental health

By SharpBrains | January 4, 2018

___ Pear Ther­a­peu­tics rakes in $50M to devel­op addi­tion­al dig­i­tal ther­a­peu­tics (Mobi­Health­News): “Boston- and San Fran­­cis­­co-based Pear Ther­a­peu­tics, mak­er of a pre­scrip­tion dig­i­tal ther­a­peu­tic plat­form, announced today the clo­sure of $50 mil­lion in Series B fund­ing. The round was led by Sin­­ga­­pore-based invest­ment com­pa­ny Temasek, with par­tic­i­pa­tion from return­ing investors 5AM Ven­tures, Arbore­tum Ven­tures, and…

Read More

Start-up Aira raises $12M, showing the way for cognitive science and artificial intelligence (AI) to improve the lives of blind and low vision individuals

By SharpBrains | May 17, 2017

— Aira Rais­es $12M Series B Financ­ing Led By JAZZ Ven­ture Part­ners And Arbore­tum Ven­tures (press release): “Aira’s ser­vice, which recent­ly con­clud­ed its beta-test­ing phase, is now avail­able to new users in the Unit­ed States. The tech­nol­o­gy solu­tion com­bines smart glass­es, ded­i­cat­ed band­width from Aira part­ner AT&T, and AI-enabled remote human agents to help blind…

Read More